

Squawk on the Street
CNBC
CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.
Episodes
Mentioned books

Dec 18, 2024 • 43min
2nd Hour: Countdown to the Fed, Salesforce CEO Marc Benioff, Housing Outlook for 2025 12/18/24
Marc Benioff, the visionary CEO of Salesforce, shares his excitement about the company’s plan to hire 2,000 talent to sell AI products. He emphasizes how this innovation represents a peak moment in his career. Alongside, insights are offered about the housing market outlook for 2025, highlighting the potential effects of Federal Reserve policies on this sector. The discussion touches on the impacts of advanced AI technologies and the competitive landscape, showcasing the transformative role of Salesforce’s Agent Force 2.0 in enhancing customer interactions.

Dec 18, 2024 • 3min
Cramer's Morning Take: Fed Preview, Best Buy 12/18/24
Expectations rise for a pivotal Federal Reserve meeting, hinting at a potential interest rate cut. Analysts are bullish on Best Buy, examining its adaptability in a challenging economic landscape. The conversation spotlights Best Buy's smart pricing strategies and the burgeoning consumer electronics market. Additionally, the potential impact of tariffs on sales is discussed, alongside the importance of expert setup services that enhance consumer convenience amidst changing market dynamics.

Dec 18, 2024 • 43min
Fed Decision Day, Nvidia Rebounds, Starbucks CEO's 100th Day on the Job 12/18/24
Market dynamics take center stage as experts parse the implications of the Federal Reserve's upcoming interest rate decision. Nvidia bounces back, sparking discussions around stock corrections. The new Starbucks CEO reflects on his initial 100 days amid labor challenges and stock performance woes. Meanwhile, merger talks between Honda and Nissan heat up, with Morgan Stanley selecting Disney as a top pick for 2025. Plus, a focus on the record-setting 'Magnificent 7' stocks and the Dow's notable losing streak adds to the financial drama.

Dec 17, 2024 • 3min
Cramer's Morning Take: Broadcom 12/17/24
Cramer discusses the recent 38% surge in Broadcom's stock and the Club's decision to cash in on those gains. Insights from the CEO provide an optimistic outlook on market opportunities. The conversation underscores the need for disciplined stock management, especially in the tech sector. Key players like NVIDIA, Broadcom, and AMD are analyzed, offering valuable strategies for investors navigating this competitive landscape.

Dec 17, 2024 • 44min
SOTS 2nd Hour: Nvidia in Correction Territory, Trump Takes Aim at PBMs, CNBC Fed Survey 12/17/24
Vamil Devan, a Guggenheim Securities analyst specializing in the pharmaceutical sector, dives into pressing market dynamics. He discusses Nvidia's alarming plunge into correction territory and its implications for investors. Devan also analyzes President-elect Trump’s critique of pharmacy benefit managers, poised to reshape drug pricing strategies. With insights on Pfizer’s future amidst market pressures and evolving healthcare innovations, the conversation highlights a cautious outlook for major health companies facing heightened scrutiny.

Dec 17, 2024 • 43min
Nvidia Correction, Tesla Extends Record Run, Trump Comments Cause Pain for Health Insurers 12/17/24
Nvidia is facing a significant correction, down over 10% from its peak, while Tesla is soaring to new heights thanks to an upgrade. President-elect Trump's drug pricing comments are causing turbulence for major health insurers. The team dives into the implications of the Fed's upcoming decisions and assesses the overall market landscape. There's also buzz around Databricks securing major funding, and discussions on the evolving pharmaceutical and tech sectors paired with insights on self-driving technologies.

Dec 16, 2024 • 3min
Cramer's Morning Take: Bristol Myers 12/16/24
Discover the excitement behind Bristol-Myers' stock surge thanks to promising drug developments like Cobenphie for schizophrenia. The discussion highlights impressive sales projections and the company's attractive dividend yield. A disciplined approach to investments is emphasized, encouraging selective decision-making amid market dips. Join the conversation about navigating the challenges of the current market landscape while seizing potential opportunities.

Dec 16, 2024 • 43min
SOTS 2nd Hour: Holiday Retail, Commercial Real Estate & Qualcomm vs. Arm Trial 12/16/24
Investors face a critical week with the Federal Reserve's final rate decision of 2024 looming. SoftBank's CEO, Masa Son, announced a massive $100 billion investment in the U.S. aimed at creating 100,000 AI-related jobs. In commercial real estate, post-pandemic office leasing hits new highs. Retail trends reveal strong holiday sales among accessories and beauty products, while the marketplace shifts from mutual funds to active ETFs. Key legal battles, particularly between Arm Holdings and Qualcomm, could shape the future of AI technology.

Dec 16, 2024 • 43min
Markets and Fed Decision Week, SoftBank CEO to Meet With Trump and Announce $100B U.S. Investment 12/16/24
A major week looms for the markets with the Federal Reserve's interest rate decision on the horizon. SoftBank’s CEO plans to announce a $100 billion investment in the U.S., potentially reshaping tech landscapes. Meanwhile, Tesla sees a stock surge, largely influenced by Elon Musk's political ties. Honeywell evaluates its aerospace sector amid activist pressures. Goldman Sachs remains optimistic about the S&P 500. The podcast also delves into the complexities of wealth concentration and emerging market opportunities influenced by AI and electric vehicle innovations.

Dec 13, 2024 • 4min
Cramer's Morning Take: Broadcom 12/13/24
The discussion highlights the ongoing decline in S&P 500 stocks, marking a significant moment since 2001. Broadcom’s impressive ascent to a $1 trillion market cap showcases the semiconductor giant's potential, especially in relation to AI. Strategies for aggressive debt reduction are also shared, alongside intriguing insights into market dynamics and investment opportunities. The candid conversations provide a clear glimpse into the financial landscape and what lies ahead for investors.


